Diastika Biotekindo Tbk. vs Phapros Tbk. — how do they compare? Diastika Biotekindo Tbk. trades at Rp126 (market cap 514.17B, 1.22M 24h volume), while Phapros Tbk. trades at Rp256 (market cap 211.68B, 116.4K 24h volume). The key difference: Diastika Biotekindo Tbk. is far larger — about 2.4× Phapros Tbk.'s market cap, and Diastika Biotekindo Tbk. is more actively traded (1.22M versus 116.4K). Which is the better fit depends on your goals.
| CHEK | PEHA | |
|---|---|---|
Market Cap | 514.17B | 211.68B |
Volume | 1.22M | 116.4K |
Lot | 12.25K | 1.16K |
Turnover | 155.6M | 29.27M |
Average Price | 127.05 | 251.47 |
Value | 155.6M | 29.27M |
Indicative Equilibrium Price | 126 | 256 |
Indicative Equilibrium Volume | 503 | 20 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on CHEK →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →